Your browser doesn't support javascript.
loading
Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study.
Inoue, Hiroshi; Umeyama, Michiaki; Yamada, Takako; Hashimoto, Hiroyuki; Komoto, Akira; Yasaka, Masahiro.
Affiliation
  • Inoue H; Saiseikai Toyama Hospital, Toyama, Japan. Electronic address: h-inoue@saiseikai-toyama.jp.
  • Umeyama M; Bristol-Myers Squibb K.K., Tokyo, Japan.
  • Yamada T; Bristol-Myers Squibb K.K., Tokyo, Japan.
  • Hashimoto H; Pfizer Japan Inc., Tokyo, Japan.
  • Komoto A; Bristol-Myers Squibb K.K., Tokyo, Japan.
  • Yasaka M; National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan.
J Cardiol ; 75(2): 208-215, 2020 02.
Article in En | MEDLINE | ID: mdl-31421933

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Pyridones / Atrial Fibrillation / Thromboembolism / Hemorrhage / Anticoagulants Type of study: Evaluation_studies / Observational_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: J Cardiol Journal subject: CARDIOLOGIA Year: 2020 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Pyridones / Atrial Fibrillation / Thromboembolism / Hemorrhage / Anticoagulants Type of study: Evaluation_studies / Observational_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: J Cardiol Journal subject: CARDIOLOGIA Year: 2020 Document type: Article Country of publication: